Now day’s vaccines have emerged as a triumphant preventive measure against many infectious diseases, revolutionizing the science of medicine. With this new development, namely, granting approval for the first therapeutic vaccine on a dangerous disease, this has been an extraordinary breakthrough in vaccine technology applied to cancer treatment, followed by that promise to change the face of cancer treatment and better results for patients suffering from this horrible disease. This paper addresses the development of this vaccine, how it works, what implications it brings when used, and some common questions in the consumption process.
Understanding Cancer and Its Challenges
What is Cancer?
Actually, cancer is a family of diseases characterized by
unregulated growth and spread of abnormal cells. The body cannot check this.
These outlaw cells invade surrounding tissues and metastasize to other parts of
the body through the bloodstream and the lymph system. As many as over 100
different types of cancers have already been identified, all differing
significantly in terms of severity as well as treatment modalities.
The Burden of Deadly Cancers
Of these, cancers such as pancreatic, liver, and other types
of lung cancer are highly aggressive and deadly. Usually, such cases develop
late, which also accounts for one of the major reasons behind the early
detection failure of the disease treatment. The prognosis in patients diagnosed
with such cancers is usually poor, and so there is a crying need for some new
form of treatment.
Traditional Cancer Therapy and its Warts
Some of the classical therapies that have been known for use
in cancer treatment included surgery, chemotherapy and radiotherapy. It can be
highly effective though has side effects that are severe and cannot be used in
so many patients. Most aggressive forms of cancers also tend to resist
classical therapies, and hence there is an opportunity for research in novel
forms of treatment, such as immunotherapy and vaccines.
Development of Cancer Vaccines
What Are Cancer Vaccines?
Another type of immunotherapy is known as the cancer
vaccines. These vaccines elevate the immune response of a body against the
tumors by identifying the cancer cells. Unlike vaccines used in prevention
infectious diseases, where they instruct the immune system of the body on what
to look for, in the treatment of already-existing cancers, those to be used
vaccines apply immunotherapy for improving the immune response against
tumor-specific antigens.
Types of Cancer Vaccines
Two are the types of cancer vaccines. They include the
following:
Preventive vaccines: These encompass a vaccine that is
designed to prevent the development of the disease. This is in the form of an
HPV vaccine against human papillomavirus-related cervical cancer and Hepatitis
B-related liver cancer vaccine.
Therapeutic Vaccines: The therapeutic vaccines were designed
to treat already existing cancers, informing the immune system to react against
the cancerous cells. It's a birthday to have only approved the very first
therapeutic vaccine.
First Therapeutic Cancer Vaccine in the World
Introduction to the Vaccine
Intended for halting a specific kind of a deadly cancer such
as melanoma or prostrate cancer for instance, Provenge (sipuleucel-T) is currently the
only therapeutic anticancer vaccine. This has been one of the most important
events so far in the field of cancer therapy out as a source of inspiration for
patients who had limited possibilities.
Mechanism of Action
It works by the introduction of specific antigens related to
the cancer cells inside the body. And it works this way:
- Presenting Antigens: the vaccine carries components that are
parts of the cancer cells, be it proteins or peptides. When introduced in the
body, these are engulfed by antigen-presenting cells inside the body.
- They then process antigens for presentation to T cells, the
white blood cells that take great parts in an immune response. Presentation
activates T cells so they can recognize those cells with the same antigens and
destroy them.
- Immune formation: Vaccines do create an early immune response but they promote the formation of memory T cells- a process by which the immune system learns to remember and thus better prepares itself in case of similar reoccurrence of cancer cells.
Clinical trials-Phase II and result
Clinical trial development is accompanied by strict
clinical trials. In these clinical trials, these tests assessed the
effectiveness and safety of the vaccine. In clinical trials, the vaccine was
given in these stages of treatment for patients to be treated and cured of this
particular kind of cancer as well as the overall care provided. Amongst these
crucial findings from clinical trials, the following have been notably
reported: Patients who received the vaccine and continued on their general treatment
were said to live longer than those who were not vaccinated.
- Decreased Tumor Size: Tumor size in patients with
multiple risk factors also decreased-excellent response to the vaccine.
- Possible Side Effects: The side effects of the vaccine are generally mild and most commonly, side effects were restricted to pain and erythema and induration at the injection site in the vast majority.
Implication in Cancer Therapy
A New Chapter for Cancer Treatment
It was said to be the last paradigm shift in the cancer
treatment approach since there was an approval for the very first therapeutic
cancer vaccine. The vaccine is a stark contrast compared to the common types of
treatments that directly attack the cancer. The vaccine allows the body to
fight the disease through the immune system, rather than attacking directly.
Personalized Medicine
Perhaps the most promising direction for the future of
cancer vaccines is personalized medicine. It will be able to target specific
antigens present in an individual's tumors; this will make healthcare providers more effective at developing plans to treat that particular kind of
cancer as uniquely as possible, depending upon the individual or
family-specific genetic features.
Combination Therapies
The addition of combination therapies shortly after diagnosis or concurrently with the current therapy, including chemotherapy or checkpoint inhibitors, could be the time to introduce the vaccine. In all ways, this multimodal treatment would make the overall treatment more effective and improve the outcome for the patient.
New Horizons with Vaccines
Approving the vaccine opens a whole world of possibilities for
other therapeutic vaccines against any kind of cancer. Further research only
reveals new tumor-specific antigens which are followed with the development of
vaccines intended to target such markers.
Conclusion
Development of the first vaccine against cancer used
therapeutically: a brilliant invention in the battles against deadly cancers.
New hope for the treatment of aggressive diseases finally turns on by means of
a vaccine powered by an immune system. Further empowering tailoring with
combination therapies that can significantly improve the treatment outcome, it
can pave its way into the future where vaccines in cancer care will eventually
become a given.
Such mechanisms and continuations and implications in the
research of cancer vaccines will help the patients and healthcare providers
properly interpret these findings.Indeed, further understanding will pave the
way for a rich future to improve survival rates and quality of life in cancer.
Please book an appointment with the best Oncologist in Lahore, Karachi, Islamabad, and all major cities of Pakistan through InstaCare, or call our helpline at 03171777509 to find a verified doctor for your disease.
